New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

Johnson & Johnson (NYSE:JNJ) today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

For many years, surgery was the only treatment for colorectal cancer. But now there’s a new option that’s changing care ...

Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...

This indicates that the test is as effective as colonoscopy in reducing colorectal cancer mortality in screening [programs],” ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

Jonathan Bricker, PhD, and Fred Hutch’s Health and Behavioral Innovations in Technology (HABIT) research group developed an AI-powered chatbot app called QuitBot to help more people successfully quit ...